Metabolic inhibition alters subcellular calcium release patterns in rat ventricular myocytes: implications for defective excitation-contraction coupling during cardiac ischemia and failure

Circ Res. 2005 Mar 18;96(5):551-7. doi: 10.1161/01.RES.0000159388.61313.47. Epub 2005 Feb 17.

Abstract

Metabolic inhibition (MI) contributes to contractile failure during cardiac ischemia and systolic heart failure, in part due to decreased excitation-contraction (E-C) coupling gain. To investigate the underlying mechanism, we studied subcellular Ca2+ release patterns in whole cell patch clamped rat ventricular myocytes using two-dimensional high-speed laser scanning confocal microscopy. In cells loaded with the Ca2+ buffer EGTA (5 mmol/L) and the fluorescent Ca2+-indicator fluo-3 (1 mmol/L), depolarization from -40 to 0 mV elicited a striped pattern of Ca2+ release. This pattern represents the simultaneous activation of multiple Ca2+ release sites along transverse-tubules. During inhibition of both oxidative and glycolytic metabolism using carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP, 50 nmol/L) and 2-deoxyglucose (2-DG, 10 mmol/L), there was a decrease in inward Ca2+ current (ICa), the spatially averaged Ca2+ transient, and E-C coupling gain, but no reduction in sarcoplasmic reticulum Ca2+ content. The striped pattern of subcellular Ca2+ release became fractured, or disappeared altogether, corresponding to a marked decrease in the area of the cell exhibiting organized Ca2+ release. There was no significant change in the intensity or kinetics of local Ca2+ release. The mechanism is not fully explained by dephosphorylation of L-type Ca2+ channels, because a similar degree of ICa"rundown" in control cells did NOT result in fracturing of the Ca2+ release pattern. We conclude that metabolic inhibition interferes with E-C coupling by (1) reducing trigger Ca2+, and (2) directly inhibiting sarcoplasmic reticulum Ca2+ release site open probability.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aerobiosis / drug effects*
  • Animals
  • Calcium / metabolism*
  • Calcium Channels, L-Type / physiology
  • Calcium Signaling / drug effects
  • Calcium Signaling / physiology*
  • Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone / pharmacology*
  • Cells, Cultured / drug effects
  • Cells, Cultured / metabolism
  • Deoxyglucose / pharmacology*
  • Glycolysis / drug effects*
  • Heart Failure / metabolism*
  • Heart Ventricles / cytology
  • Ion Transport / drug effects
  • Microscopy, Confocal
  • Myocardial Ischemia / metabolism*
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism*
  • Patch-Clamp Techniques
  • Rats
  • Ryanodine Receptor Calcium Release Channel / drug effects
  • Ryanodine Receptor Calcium Release Channel / metabolism
  • Sarcoplasmic Reticulum / metabolism*
  • Sodium / metabolism
  • Subcellular Fractions / metabolism

Substances

  • Calcium Channels, L-Type
  • Ryanodine Receptor Calcium Release Channel
  • Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone
  • Deoxyglucose
  • Sodium
  • Calcium